Sign In
Buy ABC
$179.98
+0 (+0%)
At Close: Nov 28, 2023
Here's Why You Should Retain AmerisourceBergen (ABC) Stock
09:46am, Wednesday, 21'st Apr 2021
AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches.
All You Need to Know About AmerisourceBergen (ABC) Rating Upgrade to Buy
12:52pm, Thursday, 08'th Apr 2021
AmerisourceBergen (ABC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2021 Earnings Release
04:15pm, Thursday, 01'st Apr 2021
VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Second Quarter of Fiscal 2021 on Wednesday, May 5, 2021, prio
AmerisourceBergen Closes $1,525,000,000 0.737% Senior Notes Due 2023 and $1,000,000,000 2.700% Senior Notes Due 2031
05:35pm, Tuesday, 30'th Mar 2021
VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced the closing of its public offering of $1,525,000,000 aggregate principal amount of its 0.737% Senior Notes
AmerisourceBergen (ABC) Hits New 52-Week High: What's Driving It?
11:22am, Friday, 26'th Mar 2021
AmerisourceBergen (ABC) is optimistic about maintaining a robust segmental performance amid the pandemic-led business disruptions.
AmerisourceBergen Prices $1.525 Billion 0.737% Senior Notes Due 2023 and $1.0 Billion 2.700% Senior Notes Due 2031
06:41pm, Thursday, 25'th Mar 2021
VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it priced $1.525 billion aggregate principal amount of its 0.737% Senior Notes due March 15, 2023 (th
AmerisourceBergen: This SWAN Is Still On Sale, Here's Why
06:28am, Wednesday, 24'th Mar 2021
AmerisourceBergen has underperformed the market, despite strong and steady performance.
Building A Dividend Growth Portfolio From Scratch In Today's Expensive Market
05:00am, Thursday, 18'th Mar 2021
The current valuation suggests that investors purchasing the index today could suffer through negative returns for the next 2 to 3 years or longer. Low interest rates have generated strong demand for
3 Stocks to Capitalize on Promising Dental Supplies Industry
12:08pm, Wednesday, 10'th Mar 2021
3 Stocks to Capitalize on Promising Dental Supplies Industry
Why Is AmerisourceBergen (ABC) Down 6.3% Since Last Earnings Report?
12:08pm, Saturday, 06'th Mar 2021
AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock?
AmerisourceBergen CEO on how U.S. vaccine distribution is going
11:33am, Tuesday, 02'nd Mar 2021
Steve Collis, AmerisourceBergen CEO, joins 'Squawk on the Street' to discuss the role his company has played in the federal retail pharmacy program and his thoughts on the vaccine distribution.
AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q1 2021 Results - Earnings Call Transcript
02:53pm, Thursday, 04'th Feb 2021
AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q1 2021 Results - Earnings Call Transcript
AmerisourceBergen (ABC) Q1 Earnings & Revenues Beat Estimates
10:35am, Thursday, 04'th Feb 2021
AmerisourceBergen's (ABC) fiscal first-quarter results benefit from segmental growth.
AmerisourceBergen (ABC) Q1 Earnings and Revenues Top Estimates
08:19am, Thursday, 04'th Feb 2021
AmerisourceBergen (ABC) delivered earnings and revenue surprises of 12.37% and 3.84%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
AmerisourceBergen's stock surges after profit and revenue beats, raised outlook
06:43am, Thursday, 04'th Feb 2021
Shares of AmerisourceBergen Corp. rallied 2.9% in premarket trading Thursday, after the pharmaceuticals and health care products development and delivery company reported fiscal first-quarter profit a
